XT-7

General Information


DRACP ID  DRACP02477

Peptide Name   XT-7

Sequence  GLLGPLLKIAAKVGSNLL

Sequence Length  18

UniProt ID  P84381 

PubChem CID  Not available

Origin  Xenopus tropicalis (Silurana tropicalis)

Type  Native peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma LC50=75 µM CytoTox 96 non-radiactive cytotoxicity assay  1 h 1

Hemolytic Activity  Human erythrocytes: LC50=140 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02477

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C83H149N21O21

Absent amino acids  CDEFHMQRTWY

Common amino acids  L

Mass  208066

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  10

Net charge  2

Boman Index  2378

Hydrophobicity  112.22

Aliphatic Index  178.89

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18554256

Title  Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7

Doi 10.1111/j.1747-0285.2008.00671.x

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3157

DRACP is developed by Dr.Zheng's team.